Approximately 7 million people suffer from Parkinson's and Alzheimer's diseases in the United States alone. Prof. Moussa B.H. Youdim, Director of the Eve Topf and U.S. National Parkinson Foundation Centers of Excellence in Technion's Rappaport Faculty of Medicine, discusses the neurorestoration properties of the breakthrough drugs being developed in his laboratory that promise hope for millions of Parkinson's and Alzheimer's patients throughout the world. Interview filmed in April 2011.
All Comments